Company Overview
Snapshot
Founded in January 2016 by Gabriel Siegel and Dan Regelman, Augmentiqs operates with 1–10 employees. The company has secured funding across three rounds and holds one patent. In March 2020, Augmentiqs announced a technical partnership and integration with Inspirata, enhancing its digital pathology platform.
Business overview
Augmentiqs develops a digital pathology platform that transforms traditional microscopes into smart, connected devices. Its core technology integrates an embedded camera, augmented reality for the eyepiece, and real-time stage activity tracking, enabling multi-directional communication between the microscope and a PC. This allows pathologists to maintain optical quality while accessing pathology software directly from within the microscope. The platform supports real-time telepathology, quantitative image analysis, AI training, LIS integration, and workflow tracking, serving markets such as Asia, Europe, Russia, India, Israel, Tanzania, and the United States within the Health Tech & Life Sciences sector.
Strategic signal
In March 2020, Augmentiqs announced a technical partnership and integration with Inspirata. This collaboration is significant as it validates Augmentiqs' technology within the digital pathology ecosystem and suggests a strategic move towards broader market adoption and enhanced functionality for pathologists, signaling potential for increased commercial traction and platform integration.
Log in to access full profile ›Company Intelligence Q&A
- What is Augmentiqs' primary focus?
- Augmentiqs focuses on transforming traditional microscopes into smart, connected digital pathology devices, integrating augmented reality and real-time tracking for enhanced diagnostic capabilities.
- When was Augmentiqs founded?
- Augmentiqs was founded in January 2016.
- Who are the founders of Augmentiqs?
- Augmentiqs was co-founded by Gabriel Siegel and Dan Regelman.
- What was a key strategic partnership for Augmentiqs?
- In March 2020, Augmentiqs announced a new technical partnership and integration with Inspirata, aiming to enhance digital pathology solutions.
- What type of funding has Augmentiqs received?
- Augmentiqs has received funding across three rounds, including a grant from the Israel Innovation Authority in March 2016 and support from the Luminate NY Accelerator in November 2018.